source
- Healthcare systems lag behind rapid expansion of GLP-1 therapies, raising care and trust challengesGLP-1 drugs have demonstrated that pharmacological treatment can effectively reduce obesity, and regulators have now approved them for additional uses such as cardiovascular risk reduction, metabol…
- Regulators call for unified AI guidelines in drug development at RAPS Convergence 2026Regulators and industry experts gathered at RAPS Convergence 2026 in Charlotte, NC to discuss the growing role of artificial intelligence in drug development. The panel highlighted that differing…